Home   >   Projects   >   ADAPTEA

ADAPTEA

Biomarker-driven Adaptive Virtual Reality Stimulation for ASD Interventions

Field
National
Date
01/06/2021 - 30/06/2024
Industry
  • NeuroDevelopment
  • Salud
Budget
0,5 M€
Funded by

AEI

PROJECT INFORMATION

DESCRIPTION

The overall goal of the ADAPTEA project is to design, develop and test a biomarker-based adaptive virtual reality (BAVR) system for ASD interventions using a computational psychiatry paradigm based on psychophysiological and behavioral biomarkers while exposed to replications of complex social conditions using virtual reality interfaces. The central hypothesis of this project states that biomarker-driven adaptive virtual reality (BAVR) stimulation may be a useful clinical tool for ASD interventions. This new paradigm proposed by ADAPTEA not only has the potential to generate impactful contributions in clinical areas related to ASD, but also provides remarkable methodological contributions. Although some of the tools (VR, biosignal processing, machine learning) to be used in ADAPTEA are known and well established, the interest of the project is not phenomenological but methodological. The proposed tool (BAVR), guided by a paradigm of computational psychiatry based on Bayesian theories of autism, constitutes a radical change in the treatment of ASD and will face complex technical and methodological challenges extremely relevant to the area of neurodevelopmental disorders in general, and more specifically, to ASD.

The overall goal of the ADAPTEA project is to design, develop and test a biomarker-based adaptive virtual reality (BAVR) system for ASD interventions using a computational psychiatry paradigm based on psychophysiological and behavioral biomarkers while exposed to replications of complex social conditions using virtual reality interfaces. The central hypothesis of this project states that biomarker-driven adaptive virtual reality (BAVR) stimulation may be a useful clinical tool for ASD interventions. This new paradigm proposed by ADAPTEA not only has the potential to generate impactful contributions in clinical areas related to ASD, but also provides remarkable methodological contributions. Although some of the tools (VR, biosignal processing, machine learning) to be used in ADAPTEA are known and well established, the interest of the project is not phenomenological but methodological. The proposed tool (BAVR), guided by a paradigm of computational psychiatry based on Bayesian theories of autism, constitutes a radical change in the treatment of ASD and will face complex technical and methodological challenges extremely relevant to the area of neurodevelopmental disorders in general, and more specifically, to ASD.

Impact

Our research area delves into the application of Emerging Technologies within the so-called Neurodevelopmental Disorders, either Autism Spectrum Disorder (ASD) or Attention Deficit Hyperactivity Disorder (ADHD), the goal is to implement Immersive Virtual Environments (EVI) or Multitouch technologies that, together with physiological measurement devices (Eye Tracking, Electrodermal Activity, Movement...), can provide specialized professionals with a quantitative support for the assessments that are currently performed.), can provide specialized professionals with quantitative support for the assessments that are currently carried out.

Entities

UPV, Fundación clínica Terrasa

Contact information

Mariano L. Alcañiz Raya
Project coordinator

upv

Technological capabilities

IA
AI-based immersive extended reality (VR/AR) technologies